Skip to content

Drug interactions

Empagliflozin-linagliptin + Glyburide

Severity: Moderate

Empagliflozin-linagliptin and Glyburide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Glyburide combined with linagliptin and empagliflozin increases the likelihood of hypoglycemia, which can be prolonged with glyburide especially in older adults or those with renal impairment.

What this interaction means in plain words

Empagliflozin-linagliptin and Glyburide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Empagliflozin-linagliptin belongs to Endocrine; Glyburide belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose lowering from insulin secretagogue plus DPP-4 and SGLT2 inhibition.

What to do

Consider reducing the glyburide dose when initiating the combination and monitor glucose closely. Consider a lower-risk sulfonylurea in older patients.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Glyburide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin-linagliptin with Glyburide?

MediHelp rates the interaction as moderate. Empagliflozin-linagliptin and Glyburide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Glyburide combined with linagliptin and empagliflozin increases the likelihood of hypoglycemia, which can be prolonged with glyburide especially in older adults or those with renal impairment.

How serious is the interaction between Empagliflozin-linagliptin and Glyburide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider reducing the glyburide dose when initiating the combination and monitor glucose closely. Consider a lower-risk sulfonylurea in older patients.

What other medicines interact with Empagliflozin-linagliptin?

MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in